Aprroach to"re-precision"on the diagnosis of lung adenocarcinoma
10.13315/j.cnki.cjcep.2025.06.001
- VernacularTitle:浅谈肺腺癌病理诊断的"再精准"
- Author:
Qiang ZHENG
1
;
Yuan LI
1
Author Information
1. 复旦大学附属肿瘤医院病理科,上海 200032;复旦大学上海医学院肿瘤学系,上海 200032
- Publication Type:Journal Article
- Keywords:
lung adenocarcinoma;
precise diagnosis;
infiltrative component;
high-risk factors
- From:
Chinese Journal of Clinical and Experimental Pathology
2025;41(6):701-705,718
- CountryChina
- Language:Chinese
-
Abstract:
Since the release of the fifth edition of the WHO classification of lung tumors in 2021 and the ninth edi-tion of the TNM staging system for lung cancer in 2024,pathological diagnosis of lung cancer has become increasingly standardized and precise.This development also imposes new requirements and challenges for pathologists.The authors have observed that the consistency and reproducibility of criteria and guidelines in the pathological diagnosis of lung cancer among pathologists across different institutions remain suboptimal.Among various thoracic tumors,the patholog-ical diagnosis of lung adenocarcinoma is particularly complex and is most closely associated with clinical treatment deci-sions.In recent years,significant advancements have been made in the histopathology and molecular pathology of lung adenocarcinoma,drawing considerable attention from clinicians.Based on the work experience of our department,the authors systematically reviewed the key points,difficulties,and critical issues in the pathological diagnosis of lung ade-nocarcinoma and proposed the concept of"re-precision",aiming to provide insights and benefits to domestic pathologi-cal colleagues.
